Who We Are

Shaping Discovery, Improving Life

Life Technologies enables people to accelerate scientific exploration, driving to discoveries and developments that make life even better.

Success requires passion, intellectual curiosity and a sense of urgency. We will strive for excellence and act with unyielding integrity in everything we do so that we can serve as responsible stewards in the global life science community.

We’re awed by the possibilities of biotechnology to advance the cutting edge of medicine, genetics, forensics, agriculture and environmental health. Our rich history and unique market position prepare us for an exceptionally promising future. Our approximately 9,500 employees in 110 countries span miles and disciplines, united in an avid commitment to transform life. Together, we leverage our preeminence in our industry to remain our customers’ first choice as we respond to the most crucial challenges facing humankind.

From the university to the lab to the field, we anticipate the needs of the scientific community to facilitate the quality, scope and speed of research. Because the stakes are so high, a sense of urgency propels our innovation process with uncommon momentum, fueling a voracious appetite for discovery. With our employees, customers, vendors and suppliers across the globe, we’re working to improve the human condition every day.

If you’re ready to take charge of your impact in the world, you can do it here. Join great people with great minds at Life Technologies as we continue to make life even better.

Search for jobs now >

News

  • TGen Study

    LifeTechnologies Corporation announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies. The goal of this first-of-its-kind research collaboration is to demonstrate whether genomic sequencing of cancer tissue can provide clues for treatment strategies for these individuals.

    Read All Close
  • SMS Technology

    Life Technologies Corporation announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.

    Read All Close
  • SOLiD PI ANNOUNCED

    Life Technologies Corporation today announced plans for the Applied Biosystems SOLiD(TM) PI System, a new highly accurate, flexible and easy-to-use genomic analysis platform that will bring next-generation sequencing within the grasp of all life science research laboratories worldwide. Early customer adoption of the SOLiD PI System is expected to begin in the second half of 2010.

    Read All Close

Life (Common Stock)